Infectious Disease Diagnostics Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

The global infectious disease diagnostics market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. The burden of infectious diseases on the world is overwhelming. The advent of advanced technologies such as machine learning (ML) and artificial intelligence (AI) has brought a paradigm shift in the manner in which a disease is diagnosed. Clinical microbiology laboratories have been transforming the manual processing of specimens to technology-driven automation and digitalization. Using AI to diagnose infectious diseases has many advantages.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/infectious-disease-diagnostics-market

For instance, AI can recognize signs and symptoms of infectious diseases before they’re noticeable to human senses. It can also predict disease outbreaks, helping hospitals react to prevent infections from spreading among their patients and staff. the growing implementation of AI-enabled diagnostic procedures for accurate and speedy diagnosis of diseases is anticipated to drive the global infectious disease diagnostic market. For instance, in October 2021, Roche has collaborated with PathAI for the development of artificial intelligence (AI) based digital pathology applications for enhanced patient care. As part of the development and distribution agreement, the partnership will focus on the development of an embedded image analysis workflow for pathologists. The new workflow will enable to the integration of PathAI image analysis algorithms into NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028
  • Segment Covered- 

o          By Product & Solution

o          By Technology

o          By Disease Type

o          By End-User

  • Regions Covered-

o          North America

o          Europe

o          Asia-Pacific

o          Rest of the World

  • Competitive Landscape- including HYUNDAI Steel, Nippon Steel Corp., SAIL (Steel Authority Of India), Tata Steel, United States Steel, JSW, SMS Group GmbH, and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o          Deviation from the pre-COVID-19 forecast

o          Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Infectious Disease Diagnostics Market Report Segment

By Product & Solution

  • Consumables
  • Instruments
  • Software & Services

By Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • DNA Microarray Technology
  • Other Technologies

By Disease Type

  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Hospital-Acquired Infections (HAIS)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Other Diseases

By End-User

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Academics/Research Institutes
  • Others

A full report of Infectious Disease Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/infectious-disease-diagnostics-market

Infectious Disease Diagnostics Market– Segment by Region

North America           

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific   

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa
  • Latin America

Company Profiles

  • Becton, Dickinson and Company
  • bioMérieux S.A.
  • Chembio Diagnostic Systems
  • Danaher Corp.
  • DiaSorin S.p.A.
  • ELITech Group
  • Genetic Signatures Ltd.
  • Grifols S.A.
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • Meril Life Sciences Pvt. Ltd.

Reasons to Buying From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.